Prac-tic

RSS

pyriprole

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 06/09/2018

Authorisation details

Product details
Name
Prac-tic
Agency product number
EMEA/V/C/000103
Active substance
pyriprole
International non-proprietary name (INN) or common name
pyriprole
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AX26
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
10
Date of issue of marketing authorisation valid throughout the European Union
18/12/2006
Contact address
Heinz-Lohmann-Str 4
27472 Cuxhaven
Germany

Product information

27/08/2018 Prac-tic - EMEA/V/C/000103 - T/0025

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Ectoparasiticides for topical use

Therapeutic indication

Treatment and prevention of flea infestation (Ctenocephalides canis and C. felis) in dogs. Efficacy against new infestations with fleas persists for a minimum of 4 weeks.

Treatment and prevention of tick infestation (Ixodes ricinus, Rhipicephalus sanguineus, Ixodes scapularis, Dermacentor reticulatus, Dermacentor variabilis, Amblyomma americanum) in dogs. Efficacy against ticks persists for 4 weeks.

Assessment history

How useful was this page?

Add your rating